Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$3.4100
-2.7600 ( -23.71% ) 7.4M

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$3.4100

Previous close


$6.1700

Volume


7.4M

Market cap


$218.44M

Day range


$3.1300 - $6.2500

52 week range


$2.2800 - $19.0500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 49 Nov 21, 2024
8-k 8K-related 118 Nov 15, 2024
8-k 8K-related 13 Nov 12, 2024
10-q Quarterly Reports 78 Nov 12, 2024
8-k 8K-related 15 Oct 11, 2024
8-k 8K-related 16 Sep 20, 2024
8-k 8K-related 13 Sep 05, 2024
8-k 8K-related 11 Aug 30, 2024
8-k 8K-related 11 Aug 19, 2024
10-q Quarterly Reports 80 Aug 13, 2024

Latest News